Assess for metastatic disease following radioiodine treatment
Philips NM Clinical Science
Courtesy of Washington Hospital Center in Washington D.C., USA.
This 51 year-old male with thyroid cancer was referred for an iodine-131 scan on the BrightView XCT system to assess for metastatic disease and to evaluate dosimetry following radioiodine treatment.
1 mm isotropic voxels
The images acquired on the BrightView XCT showed thyroid remnants in the thyroid bed, left cervical lymph node metastases and bilateral lung field metastases, and radiotracer accumulation in the right hip region.
SPECT/CT identified a new finding in the right intertrochanteric region - a weight-bearing area that will require orthopedic involvement (i.e. pin placement). The images provided information regarding a pathological fracture prone area.
* Results from case studies are not predictive of results in other cases. Results in other cases may vary.